The UK has begun its COVID-19 vaccination program, with Margaret, a 90-year-old, being the first to receive the vaccine. Professor Peter Openshaw highlights the rapid development of the vaccine as a scientific success. The vaccine is initially distributed to hospitals for over 80s and frontline workers. However, the Pfizer vaccine's storage requirements pose logistical challenges. Experts like Professor Gary McLean express concerns about distribution. The government is optimistic about future vaccines that may not require such stringent storage conditions. The world watches as the UK leads in this vaccination effort.

Who was the first person to receive the COVID-19 vaccine in the UK?

• Professor Gary McLean

• Margaret

• Doctor Matt Morgan

• Professor Peter Openshaw

What is a significant challenge in distributing the Pfizer-BioNTech vaccine?

• It requires storage at minus 70 Celsius

• It is not approved by regulators

• It is only effective for people over 80

• It can only be administered in London

Which group of people is prioritized for the initial vaccine administration?

• Only government officials

• All UK citizens

• Frontline healthcare workers and people over 80

• Children under 12

What is a concern regarding the Pfizer vaccine mentioned by experts?

• It may be difficult to distribute away from hospitals

• It has a short shelf life

• It is not effective against new virus strains

• It is too expensive to produce

What is the UK government's strategy regarding future vaccines?

• To distribute vaccines only in urban areas

• To stop the vaccination program

• To wait for vaccines that do not require extreme storage conditions

• To rely solely on the Pfizer vaccine